Both in Biotechnology
CRISPR Therapeutics AG vs CG Oncology
Over the past year CRSP returned −19.6% and CGON returned +49.5%; their daily moves had a correlation of 0.27.
CRSP −19.6% CGON +49.5%Growth of $1, one year, split-adjusted
| Metric | CRSP | CGON |
|---|---|---|
| Price | $51.42 | $64.68 |
| Market cap | $4.97B | $5.73B |
| Today | −5.23% | +1.91% |
| 1 month | −7.3% | −5.4% |
| 6 months | −0.4% | −2.4% |
| Year to date | −1.9% | +55.8% |
| 1 year | −17.8% | +50.5% |
| Revenue growth (YoY) | +1041.4% | — |
| Gross margin | 100.0% | −239.2% |
| Net margin | −895.3% | −6832.8% |
| P/E (TTM) | — | — |
| Price / sales | 371.3× | 920.6× |
| Net cash | $1.78B | $1.03B |
| Dividend yield | — | — |
| Volatility (60d) | 53.4% | 40.3% |
| Short % of float | 21.0% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).